More About Center for Epigenetics Research Minus iconIcon indicating subtraction, or that the element can be closed. Plus IconIcon indicating addition, or that the element can be opened. Arrow (down) icon.An arrow icon, usually indicating that the containing element can be opened and closed.

Clinical Trials

MSK scientists are at the forefront of epigenetic drug discovery, with four new compounds in early-stage clinical investigation. The following phase I trials are investigating the safety and potential effectiveness of these drugs in leukemias and other blood disorders: